NEOGEN CORP (NEOG)
Health Care · food safety diagnostics and animal health testing · NASDAQ
Neogen provides food and animal safety solutions including diagnostics, pathogen detection, and genomics products for food manufacturers and livestock producers.
What NEOGEN CORP does
Neogen Corporation is a provider of diagnostic, detection, and genomics solutions for the food and animal safety markets. The company manufactures and sells product and service offerings focused on pathogen detection, genomics, and safety testing for food companies, meat processors, and livestock producers. Its portfolio includes diagnostics for microbial and contaminant detection across food supply chains and animal health applications. The company operates in competitive markets with significant acquisition-driven growth history, though recent periods show revenue pressure and profitability challenges.
Themes: ["food safety","diagnostics","pathogen detection","animal health","genomics","food supply chain"]
Fundamentals
- Price$9.75 as of 2026-07-09 close
- Market cap$2.1B as of 2026-07-10
- 1-year return+77.3% as of 2026-07-09 close
- Net margin-69.9% as of 2026-07-10
- Gross margin+45.2% as of 2026-07-10
- ROE-29.0% as of 2026-07-10
- Debt / equity0.38 as of 2026-07-10
- Revenue growth (YoY)-3.9% as of 2026-07-10
- Revenue CAGR (3y)+19.3% SEC XBRL
- Beta1.81 as of 2026-07-10
Key risks (from latest filing)
["Revenue declining year-over-year with negative 3.91% growth and significant profitability challenges with -69.93% net margin, indicating operational or integration difficulties","Substantial goodwill and intangible assets ($1,047.8M and $1,341.8M respectively) relative to total assets, creating impairment risk if acquired business values deteriorate further","High debt load ($793.3M non-current debt plus interest expenses) limiting financial flexibility while company operates at a loss"]
Competitors & peers
- bioMérieux
- Hygiena
- Invisible Sentinel (part of bioMérieux)
- 3M Food Safety
- Romer Labs
- EMSL Analytical
- Neogen's primary public peers in diagnostics include Quest Diagnostics (DGX) and LabCorp (LH)
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.